SCHEMBL3401501

SCHEMBL3401501

CCOC(=O)NC[Si](OCC)(OCC)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GLA P06280 1/20 0.37
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ACHE P22303 1/20 0.35
ALOX15 P16050 1/20 0.34
SOAT1 P35610 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477359 0.85 EPHX1 (0.41) GAAMGAMSIMGAM2TSHR
SCHEMBL14725999 0.85 ACHE (0.51) ALDH1A1ACHE
SCHEMBL3691270 0.83 KMT2A (0.40) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL15823494 0.83 GAA (0.37) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL5968316 0.82 GAA (0.38) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL5916903 0.82 KMT2A (0.42) GAAMGAMSIMGAM2KMT2A
Ammonia Solution, Strong SCHEMBL28104105 0.80 GAA (0.37) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL6943568 0.80 SMN1; SMN2 (0.39) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL139102 0.79 ACHE (0.48) KMT2AGLAACHE
SCHEMBL11136315 0.78 GAA (0.42) GAAMGAMSIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357502-A1 CROSS-LINKABLE COMPOSITIONS BASED ON ORGANYL OXYSILANE-TERMINATED POLYMERS WACKER CHEMIE AG (DE) 2023-11-09 US disclosed
CN-114787299-B Crosslinkable compositions based on organooxysilane-terminated polymers 瓦克化学股份公司 2023-04-11 CN disclosed
CN-114787299-A Crosslinkable compositions based on organooxysilane-terminated polymers 瓦克化学股份公司 2022-07-22 CN disclosed
WO-2021110281-A1 CROSS-LINKABLE COMPOSITIONS BASED ON ORGANYL OXYSILANE-TERMINATED POLYMERS WACKER CHEMIE AG (DE) 2021-06-10 WO disclosed
CN-107108666-B The production of isocyanate-functional organosilan 瓦克化学股份公司 2019-11-22 CN disclosed
CN-110402272-A For producing the cross-linking method for obtaining elastomer compositions WACKER CHEMIE AG 2019-11-01 CN disclosed
EP-3221324-B1 PRODUCTION OF ISOCYANATE FUNCTIONAL ORGANOSILANES WACKER CHEMIE AG (DE) 2019-05-01 EP disclosed
CN-109563370-A The cross-linking coating of polymer based on organoxysilanes sealing end 瓦克化学股份公司 2019-04-02 CN disclosed
US-10155779-B2 Production of isocyanate functional organosilanes WACKER CHEMIE AG (DE) 2018-12-18 US disclosed
US-9914744-B2 Method for producing carbamatoorganosilanes WACKER CHEMIE AG (DE) 2018-03-13 US disclosed
US-20090005498-A1 Curable silyl-containing polymer composition containing paint adhesion additive MOMENTIVE PERFORMANCE MATERIALS INC. 2009-01-01 US disclosed
CN-1285678-C Alcoxy cross-linking single-component mosture-hardening materials CONSORTIUM GENERAL TEXTILE (DE) 2006-11-22 CN disclosed
US-20060247407-A1 Polymers with urea groups and silyl groups and production and use thereof HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) 2006-11-02 US disclosed
US-7057001-B2 Polymers with urea groups and silyl groups and production and use thereof HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2006-06-06 US disclosed
US-20050260401-A1 Polymers with urea groups and silyl groups and production and use thereof HENKEL AG & CO. KGAA (DE) 2005-11-24 US disclosed
CN-1538993-A Alcoxy cross-linking single-component mosture-hardening materials 电化学工业有限公司(国际) 2004-10-20 CN disclosed
EP-1328586-A1 POLYMERS WITH UREA GROUPS AND SILYL GROUPS AND PRODUCTION AND USE THEREOF Henkel Kommanditgesellschaft auf Aktien (DE) 2003-07-23 EP disclosed
WO-2002034838-A1 POLYMERS WITH UREA GROUPS AND SILYL GROUPS AND PRODUCTION AND USE THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-05-02 WO disclosed
US-5886205-A Process for producing silicon-containing isocyanate compound TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-23 US disclosed
EP-0864574-A2 Process for producing silicon-containing isocyanate compound TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10155779-B2 Production of isocyanate functional organosilanes PKD1, PCK1, PRKCA GAA 1600/4885MGAM 1611/4885SI 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.